Clinical trial
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
NCT02666378 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 10, 2018
- Completion date
- July 10, 2024
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer